Waters Corporation logo
Waters Corporation (WAT)
Compare

Waters Corporation (WAT) Free Cash Flow CAGR:-56.80%(TTM)

Stocks/WAT Stock/Performance/free cash flow cagr
Compare

The free cash flow cagr for Waters Corporation (WAT) is -56.80% over the latest trailing 12-month period. Free cash flow CAGR uses precomputed cash-flow statement history.

The free cash flow cagr for Waters Corporation (WAT) stock is -56.80% over the past 12 months. The 3 year average growth rate is -15.17% and the 5 year cagr is -17.63%. Free cash flow CAGR measures how Waters Corporation's cash generation has grown. FCF represents the cash available for dividends, buybacks, debt reduction, or reinvestment.

WAT Free Cash Flow CAGR Chart

Waters Corporation (WAT)

WAT Free Cash Flow CAGR History

YearStart FCFEnd FCFChange% ChangeCAGR
2025$619.64M$539.81M$-79.83M-12.88%-12.88%
2024$442.18M$619.64M+$177.47M+40.13%+40.13%
2023$428.20M$442.18M+$13.97M+3.26%+3.26%
2022$579.01M$428.20M$-150.80M-26.05%-26.05%
2021$618.12M$579.01M$-39.12M-6.33%-6.33%
2020$479.26M$618.12M+$138.86M+28.97%+28.97%
2019$476.88M$479.26M+$2.38M+0.50%+0.50%
2018$607.17M$476.88M$-130.29M-21.46%-21.46%
2017$534.11M$607.17M+$73.06M+13.68%+13.68%
2016$457.28M$534.11M+$76.83M+16.80%+16.80%
2015$405.40M$457.28M+$51.88M+12.80%+12.80%
2014$366.43M$405.40M+$38.97M+10.64%+10.64%
2013$344.53M$366.43M+$21.89M+6.36%+6.36%
2012$411.94M$344.53M$-67.41M-16.36%-16.36%
2011$395.12M$411.94M+$16.82M+4.26%+4.26%
2010$324.47M$395.12M+$70.65M+21.77%+21.77%
2009$349.18M$324.47M$-24.72M-7.08%-7.08%
2008$310.17M$349.18M+$39.02M+12.58%+12.58%
2007$212.17M$310.17M+$97.99M+46.18%+46.18%
2006$247.02M$212.17M$-34.85M-14.11%-14.11%
2005$193.21M$247.02M+$53.81M+27.85%+27.85%
2004$122.42M$193.21M+$70.79M+57.83%+57.83%
2003$181.68M$122.42M$-59.26M-32.62%-32.62%
2002$146.74M$181.68M+$34.94M+23.81%+23.81%
2001$140.22M$146.74M+$6.52M+4.65%+4.65%
2000$128.40M$140.22M+$11.82M+9.20%+9.20%
1999$92.00M$128.40M+$36.40M+39.57%+39.57%
1998$-82.80M$92.00M+$174.80M+0.00%N/A
1997$45.60M$-82.80M$-128.40M-281.58%N/A

Quarterly Free Cash Flow — QoQ & YoY

QuarterValueQoQYoY
Q1 2026-$42.00M-133.4%-118.0%
Q4 2025$125.58M-22.4%-33.2%
Q3 2025$161.87M+772.8%-9.5%
Q2 2025$18.55M-92.1%+0.6%
Q1 2025$233.81M+24.3%-0.2%
Q4 2024$188.03M+5.1%-0.3%
Q3 2024$178.96M+871.0%+49.4%
Q2 2024$18.43M-92.1%+164.7%
Q1 2024$234.22M+24.2%+44.3%
Q4 2023$188.53M+57.4%+38.1%
Q3 2023$119.77M+520.4%+2.8%
Q2 2023-$28.49M-117.5%-260.9%
Q1 2023$162.36M+18.9%-1.8%
Q4 2022$136.53M+17.2%-21.2%
Q3 2022$116.46M+557.6%-9.1%
Q2 2022$17.71M-89.3%-82.0%

QoQ = change vs the prior quarter; YoY = change vs the same quarter a year earlier.

About Waters Corporation

Waters Corporation is a global leader in specialized measurement, delivering analytical solutions across Asia, the Americas, and Europe. The company operates through two main divisions: Waters and TA. Under its Waters segment, it engineers, manufactures, sells, and provides support for high and ultra-performance liquid chromatography and mass spectrometry (MS) systems. This includes essential consumables like chromatography columns and comprehensive post-warranty service plans. The TA segment focuses on designing, producing, selling, and servicing instruments for thermal analysis, rheometry, and calorimetry. Additionally, Waters develops and supplies sophisticated software that integrates with both its own instruments and those from other manufacturers. The company's advanced MS technology plays a crucial role in various applications, such as drug discovery and development (including clinical trial assessments), analyzing proteins involved in disease processes, ensuring nutritional safety, and conducting environmental testing. Its thermal analysis, rheometry, and calorimetry instruments are vital for assessing the suitability and stability of a wide range of materials, including fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids. These instruments support diverse sectors like industrial manufacturing, consumer goods, healthcare products, and life science research. Waters' extensive client base spans the life sciences, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental sectors, where its products are instrumental in research and development, quality assurance, and general laboratory operations. Established in 1958, Waters Corporation is headquartered in Milford, Massachusetts.

Milford, MA
7,600 employees
Healthcare / Medical - Diagnostics & Research
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Udit Batra